Researchers and clinicians now have a greater understanding of what health agencies formally call post-COVID condition, but the wide spectrum of symptoms, slow progress in launching pharmacologic clinical trials, and the research toward understanding the underlying causes mean standardized diagnostic tests and definitive treatments remain elusive. This piece follows a doctor and his patient as they navigate the complexities and challenges around long COVID. Read the full story on Medscape.
Read MoreFrom reinfection risks to the leading hypotheses on the causes behind long COVID, learn more about this potentially debilitating condition in these stories written for WebMD.
Read MoreInsufficient funding from state and federal health agencies towards long COVID has led to significant hurdles in patient care, especially for vulnerable and underserved communities, according to interviews and surveys with more than a dozen clinics, doctors, advocates, and patients. At the same time, a lack of training and education on long COVID within the broader medical community is also hurting patients. I explore these challenges through the experiences of one long COVID clinic at the University of Washington.
Read MoreFrom fad diets and vitamins to “blood washing” and stem cell therapy, long COVID patients are seeking out experimental therapies in a desperate bid to find hope and relief from debilitating symptoms. But doctors worry about the potential harm – both physical and financial – some of these unproven and overhyped treatments could cause.
Read More